Instructions for Authors  by unknown
GUIDE FOR AUTHORS
Value in Health is a peer-reviewed publication of the International Society for 
Pharmacoeconomics and Outcomes Research. Its mission is to  provide a 
forum for the advancement and dissemination of knowledge and research 
in pharmacoeconomics and the health-related  outcomes of disease and 
treatment processes. The journal therefore solicits original contributions in 
applied and theoretical pharmacoeconomics, and in the theory, measure-
ment, and analysis of the health-related outcomes relevant to forwarding 
scholarly and public dialogue about the assessment of value in health and 
health care. In keeping with its broad mission, Value in Health will also ac-
cept methodology papers and critical reviews of empirical and theoretical 
literature in pharmacoeconomics and outcomes research.
Value in Health does not consider papers reporting data series or data 
sets that do not include appropriate statistical conﬁ dence intervals and/
or other measures of statistical imprecision. Value in Health also does 
not consider papers reporting modeling results that do not include sen-
sitivity analysis of key and inﬂ uential model parameters.
Authors for whom English is a second language may choose to have 
their manuscript professionally edited before submission or during 
the review process. Authors wishing to pursue a professional English-
language editing service should make contact and arrange payment with
the editing service of their choice. For more details regarding the recom-
mended services, please refer to http://support.elsevier.com/.
For more details about the types of articles that are suitable for Value
in Health, see: http://www.ispor.org/publications/value/submit.asp.
I. ETHICS IN PUBLISHING
For information on Ethics in Publishing and Ethical guidelines for journal
publication see http://www.elsevier.com/publishingethics and http:// 
www.elsevier.com/ethicalguidelines.
II. CONFLICT OF INTEREST
All authors must disclose any ﬁ nancial and personal relationships with 
other people or organisations that could inappropriately inﬂ uence (bias) 
their work. Examples of potential conﬂ icts of interest include employ-
ment, consultancies, stock ownership, honoraria, paid expert testimony, 
patent applications/registrations, and grants or other funding. See also 
http://www.elsevier.com/conﬂ ictsoﬁ nterest.
III. SUBMISSION DECLARATION
Submission of an article implies that the work described has not been 
published previously (except in the form of an abstract or as part of a 
published lecture or academic thesis), that it is not under consideration 
for publication elsewhere, that its publication is approved by all authors 
and tacitly or explicitly by the responsible authorities where the work 
was carried out, and that, if accepted, it will not be published elsewhere 
including electronically in the same form, in English or in any other lan-
guage, without the written consent of the copyright-holder.
IV. RETAINED AUTHOR RIGHTS
As an author you (or your employer or institution) retain certain rights; 
for details you are referred to: http://www.elsevier.com/authorsrights.
V. FUNDING BODY AGREEMENTS AND POLICIES
Elsevier has established agreements and developed policies to allow au-
thors whose articles appear in journals published by Elsevier, to comply 
with potential manuscript archiving requirements as speciﬁ ed as condi-
tions of their grant awards. To learn more about existing agreements and 
policies please visit http://www.elsevier.com/fundingbodies.
VI. MANUSCRIPT SUBMISSION AND  SPECIFICATIONS
To submit a manuscript to Value in Health, please go to: http://mc. 
 manuscriptcentral.com/vih. For assistance, authors may contact the 
Value in Health editorial ofﬁ ce at: viheditor@ispor.org.
If submissions are larger than 500 KB, they should be compressed 
using PKZIP or WINZIP.
Authors will be required to assign copyright of their papers. Copyright 
assignment is a condition of publication and papers will not be passed 
to the publisher for production unless copyright has been  assigned. An 
 appropriate copyright assignment form can be found at the following 
 address: http://www.ispor.org/publications/value/Value-In-Health-Copyright-
Transfer-Form_2011.pdf. A faxed copy of this completed and signed form is 
acceptable; fax to 609-586-4982 or email to: viheditor@ispor.org. 
If excerpts from other copyrighted works are included, the author(s) 
must obtain written permission from the copyright owners and credit the 
source(s) in the article. Elsevier has preprinted forms for use by authors in 
these cases: please consult http://www.elsevier.com/permissions.
Each Submission should contain separate documents as follows:
i. COVER LETTER. The cover letter should include: 1) title of the manu-
script; 2) name of the document ﬁ le(s) containing the manuscript and the 
software (and version) used; 3) name and all contact information for the 
corresponding author and a statement as to whether the data, models, 
or methodology used in the research are proprietary; 4) names of all 
sponsors of the research and a statement of all direct or indirect ﬁ nancial 
relationships the authors have with the sponsors; and 5) if applicable, a 
statement that the publication of study results was not contingent on the 
sponsor’s approval or censorship of the manuscript.
ii. TITLE PAGE. The title page should contain the following: 1) title; 2) 
full names (ﬁ rst and surname) of all authors including academic degrees 
and afﬁ liation(s); 3) name, mailing and email addresses, telephone and fax 
numbers of corresponding author (with whom all correspondence will take 
place unless other arrangements are made); 4) all sources of ﬁ nancial or 
other support for the manuscript (if no funding was received, this should be 
noted on the title page); 5) at least four key words for indexing purposes; 
and 6) a running title of not more than 45 characters including spaces.
iii. MANUSCRIPTS. Manuscripts must be written in English, typed in Mi-
crosoft Word (2003 or later; .doc or .docx ﬁ le formats). Manuscripts should 
be in 8.5x11-inch page format, double-spaced with 1-inch margins on all 
sides and size 10 font (Arial or Times New Roman fonts are preferred). 
Minimal formatting should be used, i.e., no justiﬁ cation, italics, bold, indenting, 
etc. There should be no hard returns at the end of lines. Double-spacing after 
each element is requested (e.g., headings, titles, paragraphs, legends). The 
“Uniform Requirements for Manuscripts Submitted to Biomedical Journals” 
should be consulted for speciﬁ c style issues not addressed here (www.
acponline.org, Ann Intern Med 1997;126:36-47).
a. ABSTRACT. An abstract of 250 words or less is required, 
 summarizing the work reported in the manuscript. Original research 
manuscripts should use a structured format for the abstract, i.e., 
Objectives, Methods, Results, and Conclusions.
b. TEXT. The body of the manuscript should be divided into sections 
that facilitate reading and comprehension of the material. This should 
normally include sections with the major headings: Introduction, Meth-
ods, Results, Conclusions, Acknowledgments (if needed), and Refer-
ences. There should be no footnotes. Figures (inclusive of ﬁ gure leg-
ends) and Tables must be submitted each as separate documents.
c. REFERENCES. References should be listed in a separate section 
and numbered consecutively with Arabic numerals in the order in which 
they are cited in the text. Referencing software, superscripts, or any 
other electronic format should not be used when referencing, neither in 
the text nor the reference list. Citing unpublished or non-peer-reviewed 
work such as abstracts and presented papers is discouraged. Per-
sonal communications may be indicated in the text as long as written 
acknowledgment from the authors of the communications accompa-
nies the manuscript. Reference style should follow that of Index Medi-
cus. Spell out single-word journals and abbreviate all others according 
to the style of Index Medicus. If there are more than four authors, use 
only the names of the ﬁ rst three, followed by et al. 
The three most common types of references are illustrated 
below for example.
Journal article: Surname and initials of author(s), title of article, 
name of journal, year, volume number, ﬁ rst and last page.
Arocho R, McMillan CA. Discriminant and criterion evaluation of the 
U.S.-Spanish version of the SF-36 Health Survey in a Cuban-American 
population with benign hyperplasia. Med Care 1998;36:766–72.
Book: Surname and initials of author(s)/editor(s), title and subtitle, 
volume, edition (other than ﬁ rst), city, publisher, year.
Johnston J. Econometric Methods (3rd ed.). New York: McGraw-Hill,
1984.
Chapter in Book: Surname and initials of author(s), title of chapter,
author(s)/editor(s) of book, title of book, volume, edition (other than
ﬁ rst), city, publisher, year.
Luce BR, Manning WG, Siegel JE, et al. Estimating costs in  cost-
effectiveness analysis. In: Gold MR, Siegel JE, Russell LB,  et al., 
eds., Cost-effectiveness in Health and Medicine. New York: Oxford 
University Press, 1996.
Website: Title of article on web. www.document. Available from: 
http://www... [Accessed Month day, year].
International Society for Pharmacoeconomics and Outcomes 
Research (ISPOR). ISPOR Good Outcomes Research Practices
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Index. Available from: http://www.ispor.org/workpaper/practices_ 
index.asp. [Accessed January 1, 2011].
iv. TABLES. Tables should be clearly labeled, neatly typed, and easy 
to understand without reference to the text. Each should be double-
spaced and presented on a separate page. Statistical estimates 
should indicate parameter estimates and, as appropriate, t ratios or 
standard error, statistical signiﬁ cance, sample size, and other relevant 
information. All abbreviations must be explained below each table. 
Each table should be numbered and have a self-explanatory title.
v. FIGURES. Figures should each be submitted as a separate image 
ﬁ le, not embedded in the manuscript document or in a slide presenta-
tion. Cite ﬁ gures consecutively, as they appear in the text, with Arabic 
numbers (Figure 1, Figure 2, Figure 3A, etc.). If, together with your 
accepted article, you submit usable color ﬁ gures then the Journal will 
ensure, at no additional charge, that these ﬁ gures will appear in color 
on the Web (e.g., ScienceDirect and other sites) regardless of whether 
or not these illustrations are reproduced in color in the printed version. 
There will be a charge for color reproduction in print; you will receive 
information regarding the costs from Elsevier after receipt of your ac-
cepted article. Please indicate your preference for color in print or on 
the Web only. Each ﬁ gure must be assigned a brief title (as few words 
as possible, and reserving abbreviations for the legend) as well as 
a legend. The corresponding legend should be typed double-spaced 
on a separate page. All symbols, arrows, and abbreviations must be 
explained in the legend. Please submit ﬁ les with a resolution of at least 
300 DPI. Line artwork should contain a resolution of least 1000 DPI. 
Elsevier recommends submitting ﬁ gures in the following formats: TIFF, 
JPG, EPS, and PDF. Please be sure to delete any identifying patient 
information such as name, social security number, etc. Photographs 
in which a person’s face is recognizable must be accompanied by a 
letter of release from that person explicitly granting permission for 
publication in the Journal. For any previously published material, writ-
ten permission for both print and electronic reprint rights must be 
obtained from the copyright holder. For further explanation and exam-
ples of artwork preparation, see Elsevier’s Author Artwork Instructions 
at www.elsevier.com/artwork.
vi. SUPPLEMENTAL MATERIAL. You may submit appendixes that 
describe either methods or results in more detail if these are needed 
for clarity of understanding by either peer reviewers or readers. If ap-
propriate, materials suitable for Web publication but not print publica-
tion (eg, audio or video ﬁ les, see below) can also be submitted. If you 
do so, indicate the particular reasons for the appendix and whether 
you are submitting it for possible Web publication or simply for peer 
review purposes. Value in Health accepts audio and video ﬁ les as an-
cillaries to the main article. Audio ﬁ les should be in .mp3 format; the 
recommended upper limit for the size of a single ﬁ le is 10 Mb. Video 
ﬁ les should be submitted in .mpg or .mp4 format; the recommended 
upper limit for the size of a single ﬁ le is 10 Mb. Any alternative format 
supplied may be subject to conversion (if technically possible) prior to 
online publication. 
vii. SURVEY INSTRUMENT. For papers analyzing preferences, ViH 
 requires the submission of a copy of the survey instrument (translated 
into English in case of different original language) used to generate the 
preference data. This is to help in the review process and the survey 
instrument need not appear in a ﬁ nal publication. If the authors wish 
the questionnaire to be published with the paper, it should be submit-
ted through ScholarOne Manuscripts as part of the paper. If they do 
not wish it to be published, it should be submitted through ScholarOne 
Manuscripts as Supporting Information and then will be sent to the 
reviewers as a reviewer’s appendix.
VII. DATA, MODELS, AND METHODOLOGY
All authors must agree to make their data available at the Editor’s re-
quest for examination and re-analysis by referees or other persons des-
ignated by the Editor. All models and methodologies must be presented 
in sufﬁ cient detail to be fully comprehensible to readers.
VIII. AUTHOR ANONYMITY
From September 15, 2003, it is the policy of Value in Health that peer 
review of submitted manuscripts is double blinded, i.e., the reviewers 
do not know the names of the authors of manuscripts and the authors 
do not know the names of the reviewers. Blinded reviews are common 
practice at many important scientiﬁ c and medical journals.
IX. THE REVIEW PROCESS
All manuscripts deemed appropriate for Value in Health after initial screen-
ing will be reviewed by at least two peer reviewers. The objective of the 
journal is to complete peer review and reach editorial decision within ten 
to twelve weeks of submission, at which time the corresponding author will 
receive written notiﬁ cation, including anonymous reviewer commentary.
X. AUTHOR TRACKING SERVICES
Authors may track accepted articles at http://www.elsevier.com/ track-
article and set up e-mail alerts to inform them when an article’s status 
has changed. Contact details for questions arising after acceptance of 
an article, especially those relating to proofs, will be provided by the 
publisher.
XI. PROOFS
Proofs will be sent electronically to the Authors to be carefully checked 
for printer’s errors. Substantive changes or additions to the edi-
ted manuscript cannot be allowed at this stage. Corrected proofs 
should be returned to the publisher within 2 days of receipt.
XII. OFFPRINTS
The corresponding author, at no cost, will be provided with a PDF ﬁ le 
of the article via e-mail. For an extra charge, paper offprints can be 
ordered via the offprint order form which is sent once the article is 
 accepted for publication. The PDF ﬁ le is a watermarked version of the 
published article and includes a cover sheet with the journal cover image 
and a disclaimer outlining the terms and conditions of use.
